Most people begin seeing changes, like reduced appetite or weight loss, after about 4 weeks of use
Lin CH, Hsieh SH, Sun JH, Tsai JS, Huang YY
10.1007/s00438-004-1006-8 Mol
Specifications Compound: Retatrutide (triple agonist GLP-1 / GIP / glucagon) Quantity: 10 mg per vial, lyophilized powder Purity: 99%+ HPLC standard batch-specific Certificate of Analysis included for your exact lot Identity: confirmed by LC-MS Appearance: white lyophilized powder Documentation: Every vial ships with access to a batch-specific Certificate of Analysis showing HPLC purity, mass-spectrometry identity confirmation, endotoxin, residual solvents, and water content for your exact lot
Perimenopausal women using GLP-1s and experiencing dramatic weight loss may become keenly aware of the potency and widespread nature of weight-related stigma as they notice others, including family, friends, peers, and romantic partners treating them differently because of their weight loss